Loading...
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review
The optimal dose of recombinant tissue plasminogen activator (rtPA) for acute ischaemic stroke (AIS) remains controversial, especially in Asian countries. We aimed to update the evidence regarding the use of low-dose versus standard-dose rtPA. We performed a systematic literature search across MEDLI...
Na minha lista:
| Udgivet i: | Stroke Vasc Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870642/ https://ncbi.nlm.nih.gov/pubmed/29600005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000112 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|